NEXT Financial Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History

NEXT Financial Holdings’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$216K	Buy	+525	New	+$216K	0.05%	341

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

NEXT Financial Holdings's REGN Position: Q1 2019 in Review

NEXT Financial Holdings opened a new position in Regeneron Pharmaceuticals (REGN) in Q1 2019: 525 shares worth $216K. The stake represents 0.05% of the portfolio and ranks #341 among its holdings.

718 funds tracked by Wall St. Rank hold REGN as of Q1 2019.

NEXT Financial Holdings held 525 shares of Regeneron Pharmaceuticals worth $216K as of Q1 2019.
Regeneron Pharmaceuticals was a new NEXT Financial Holdings position in Q1 2019.
Regeneron Pharmaceuticals made up 0.05% of NEXT Financial Holdings's portfolio in Q1 2019, its #341 holding.
718 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2019.

Based on NEXT Financial Holdings's 13F filing for Q1 2019, filed 13 May 2019.